drugset / Trial / NCT03914131
Clinical Trial Scheme of Xinnaoning Capsule
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a randomized, double-blind, parallel-controlled, multicenter clinical study to evaluate the efficacy and safety of Xinnaoning capsule in the treatment of chronic stable angina pectoris (Qi stagnation and blood stasis syndrome).
Timeline
- Start
- 2018-05-15
- Primary completion
- 2019-12
- Completion
- 2020-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Xinnaoning Capsule | Unknown | 3 unknown | Oral |